A Day Up For Jounce Therapeutics, Inc.
Tue, Sep 15, 2020 at 05:30 PM
Jounce Therapeutics, Inc. (JNCE:NASDAQ) jumped higher at $10.95, representing a gain of 23.7%. On Mon 14 Sep 20, JNCE:NASDAQ hit a New 2-Week High of $8.85. The stock got featured on our News Catalysts scanner on Wed 02 Sep 20 at 04:40 PM in the 'MISCELLANEOUS' category. From Mon 31 Aug 20, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Jounce Therapeutics, Inc. (JNCE:NASDAQ)
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
Top 10 Gainers:
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 192.88%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 51.66%
- IPOB (IPOB:NYSE), 34.56%
- Oasis Petroleum Inc. (OAS:NASDAQ), 28.34%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 24.27%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 24.18%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 23.73%
- Ocwen Financial Corporation (OCN:NYSE), 23.61%
- Kosmos Energy Ltd. (KOS:NYSE), 22.77%
- Mexco Energy Corporation (MXC:NYSEMKT), 20.95%